EN
登录

合成生物学研究商Arzeda获得3800万美元超额认购融资,以推进蛋白质设计商业化工作

Arzeda Secures $38M in Oversubscribed Funding Round to Advance Protein Design Commercialization Efforts

businesswire 等信源发布 2024-09-17 20:00

可切换为仅中文


SEATTLE--(BUSINESS WIRE)--Arzeda, the Protein Design Company™, today announced the closing of a $38M oversubscribed funding round. This fundraise brings in new investments from Sofinnova Partners, Fall Line Capital, Sucden Ventures, Silver Blue, and the venture arm of W.L. Gore & Associates (makers of Gore-Tex®), which has been in a joint development agreement with Arzeda since 2022.

西雅图--(商业新闻短讯)--蛋白质设计公司Arzeda今天宣布结束一轮3800万美元的超额认购融资。此次募资带来了来自Sofinnova Partners、Fall Line Capital、Sucden Ventures、Silver Blue和W.L.Gore&Associates(Gore-Tex®制造商)的风险投资部门的新投资,自2022年以来,该部门与Arzeda签订了联合开发协议。

Previous investors also participated in the round, including the venture arm of the Continental Grain Company, Bunge Ventures, and Lewis & Clark Agrifood..

此前的投资者也参与了这轮投资,包括大陆谷物公司的风险投资部门Bunge Ventures和Lewis&Clark Agrifood。

With this funding, Arzeda will expand the production capacity of its ProSweet Enzymes™ and ProSweet RebM™ to meet strong market demand of better tasting stevia and accelerate the commercialization of additional breakthrough products in its pipeline. Arzeda has partnered with several global industrial leaders to bring these products to the market including Unilever, AAK, and W.L.

有了这笔资金,Arzeda将扩大其ProSweet Enzymes™和ProSweet RebM™的生产能力,以满足口感更好的甜菊糖的强劲市场需求,并加速其管道中其他突破性产品的商业化。Arzeda与多家全球行业领导者合作,将这些产品推向市场,包括联合利华、AAK和W.L。

Gore & Associates..

戈尔公司。。

“Arzeda is at a key inflection point with its products now at commercial scale,” said Michael Krel, Partner at Sofinnova Partners. “This funding will enable Arzeda to accelerate the commercialization of its industrial biotech products, including new designer proteins and enzymes that have the ability to reduce GHG emissions.

Sofinnova Partners合伙人迈克尔·克雷尔(MichaelKrel)表示:“Arzeda的产品目前正处于商业规模的关键转折点。”。“这笔资金将使Arzeda加速其工业生物技术产品的商业化,包括具有减少温室气体排放能力的新设计蛋白质和酶。

Arzeda’s Intelligent Protein Design Technology™ is transformational to many industrial verticals and they are one of the few companies that have been able to translate this promise into commercial products that solve real- world problems and create value for the customer.”.

Arzeda的Intelligent Protein Design Technology™正在向许多垂直行业转型,他们是少数能够将这一承诺转化为解决现实问题并为客户创造价值的商业产品的公司之一。”

Arzeda’s Intelligent Protein Design Technology™ is built on one of the largest proprietary datasets of high-quality protein designs linked to experimental results and leverages the latest advances in generative artificial intelligence (AI) to design and manufacture higher-performing proteins and enzymes tailored for large-scale production.

Arzeda的Intelligent Protein Design Technology™基于与实验结果相关的高质量蛋白质设计的最大专有数据集之一,并利用生成人工智能(AI)的最新进展来设计和制造针对大规模生产量身定制的性能更高的蛋白质和酶。

Arzeda’s proteins and enzymes enable alternatives which outperform existing products across various industries, including food, personal and home care, agriculture, chemicals, materials, pharmaceuticals, and diagnostics, in a more sustainable manner..

Arzeda的蛋白质和酶能够以更可持续的方式替代各种行业的现有产品,包括食品、个人和家庭护理、农业、化学、材料、制药和诊断。

“We are impressed with the progress Arzeda has made in developing next generation materials that have superior performance with a reduced environmental footprint” said Ed Rubin, SVP of External Ventures at W.L. Gore & Associates. “We are excited to further our relationship with Arzeda through this strategic investment.”.

W.L.Gore&Associates外企高级副总裁Ed Rubin表示:“Arzeda在开发性能优异、环境足迹更小的下一代材料方面取得的进展给我们留下了深刻印象。”。“我们很高兴能通过这项战略投资进一步发展与阿尔泽达的关系。”

The biotech industry has only scratched the surface of what can be done with designed proteins, and Arzeda is on a mission to make this future a reality. “Our designed proteins and enzymes will touch every aspect of our lives in the future. I am thrilled to see Arzeda delivering on its mission” said Alexandre Zanghellini, co-founder and CEO of Arzeda.

生物技术行业只触及了设计蛋白质可以做什么的表面,Arzeda的使命是使这一未来成为现实。Arzeda联合创始人兼首席执行官亚历山大桑加利尼(AlexandreZanghellini)表示:“我们设计的蛋白质和酶将在未来触及我们生活的方方面面。我很高兴看到Arzeda完成其使命。”

“The field of protein design has experienced explosive growth in recent years but has faced challenges in translating these advances into products. Where we excel is in developing solutions that can be manufactured sustainably at scale.”.

“近年来,蛋白质设计领域经历了爆炸性增长,但在将这些进步转化为产品方面面临着挑战。我们擅长的是开发可以大规模可持续生产的解决方案。”

About Arzeda

关于阿尔泽达

Arzeda harnesses the power of Intelligent Protein Design Technology™, combining physics- based protein design and AI algorithms to create, validate, and manufacture new designer proteins and enzymes that enhance our lives and protect our planet. In collaboration with Fortune 500 companies and industrial leaders, we develop and commercialize healthier and more sustainable products across the food and nutrition, consumer products, advanced materials, agriculture, diagnostics, and pharmaceutical industries globally, fulfilling the promise of biotechnology.

Arzeda利用Intelligent Protein Design Technology™的强大功能,将基于物理的蛋白质设计和人工智能算法相结合,创建、验证和制造新的设计蛋白质和酶,以改善我们的生活并保护我们的星球。我们与财富500强公司和行业领袖合作,在全球食品和营养、消费品、先进材料、农业、诊断和制药行业开发和商业化更健康和更可持续的产品,实现生物技术的承诺。

For more information, please visit www.arzeda.com..

有关更多信息,请访问www.arzeda.com。